REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial. - Martin-Broto, Javier; Valverde, Claudia; Hindi, Nadia; Vincenzi, Bruno; Martinez-Trufero, Javier; Grignani, Giovanni; Italiano, Antoine; Lavernia, Javier; Vallejo, Ana; Tos, Paolo Dei; Le Loarer, Francois; Gonzalez-Campora, Ricardo; et al. (Molecular Cancer, 2023)